Harmony Biosciences Holdings vs Lexeo Therapeutics
Harmony Biosciences Holdings vs Lexeo Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Harmony Biosciences Holdings is on 57/100 and Lexeo Therapeutics on 61/100.
Where each one leads
Harmony Biosciences Holdings
- domain rating: 55/100 against 41/100
- headcount: 332 against 91
- LinkedIn following: 22,304 against 16,654
Lexeo Therapeutics
- our overall score: 61/100 against 57/100
At a glance
| Measure | Harmony Biosciences Holdings | Lexeo Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2017 | 2020 |
| Headquarters | Plymouth Meeting, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Harmony Biosciences Holdings | Lexeo Therapeutics |
|---|---|---|
| Employees | 332 | 91 |
| Total funding | $401M | $495M |
| Latest round | IPO | Public Offering |
| LinkedIn followers | 22,304 | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Harmony Biosciences Holdings | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 61/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 33/100 | 28/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 55/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Harmony Biosciences Holdings | Lexeo Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
Harmony Biosciences Holdings vs Lexeo Therapeutics: common questions
Which is better, Harmony Biosciences Holdings or Lexeo Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Harmony Biosciences Holdings and Lexeo Therapeutics compare on the numbers?
Harmony Biosciences Holdings leads on domain rating (55/100 against 41/100), headcount (332 against 91), LinkedIn following (22,304 against 16,654). Lexeo Therapeutics leads on our overall score (61/100 against 57/100).
Read the full Harmony Biosciences Holdings review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other Harmony Biosciences Holdings alternatives we track.